These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2702847)

  • 1. Ranitidine--bolus or infusion prophylaxis for stress ulcer.
    Böhrer H; Krier C; Jürs G; Warth S
    Crit Care Med; 1989 Apr; 17(4):381-2. PubMed ID: 2702847
    [No Abstract]   [Full Text] [Related]  

  • 2. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
    Moore JG
    DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The magnitude of nocturnal acid suppression by ranitidine 300 mg given at 18.00 hours.
    Ovartlarnporn B; Prichaworawach S; Niyomthai N; Wuthi S; Chamsai M; Tansakool U
    J Med Assoc Thai; 1992 Feb; 75(2):110-5. PubMed ID: 1645048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with ranitidine and pirenzepine for control of intragastric pH in the critically ill.
    More DG; Raper RF; Watson CJ; Shenfield GM
    Crit Care Med; 1985 Aug; 13(8):651-5. PubMed ID: 3839449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute stress bleeding prophylaxis with sucralfate versus ranitidine and incidence of secondary pneumonia in intensive care unit patients.
    Mustafa NA; Aktürk G; Ozen I; Köksal I; Erciyes N; Solak M
    Intensive Care Med; 1995 Mar; 21(3):287. PubMed ID: 7790623
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral ranitidine as stress ulcer prophylaxis: serum concentrations and cost comparisons.
    Wagner B; Nagata M
    Crit Care Med; 1994 Jan; 22(1):177-8. PubMed ID: 8124962
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
    Osteyee JL; Banner W
    Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there any benefit in the use of ranitidine in hospitalized patients, under a minor regimen of stress, in the prophylaxis of peptic ulcer or gastrointestinal bleeding?].
    Holtz JV; Grandi LM; Ecclissato PR; Bernardo WM
    Rev Assoc Med Bras (1992); 2007; 53(6):476-7. PubMed ID: 18157352
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastric pH control in critically ill children receiving intravenous ranitidine.
    Harrison AM; Lugo RA; Vernon DD
    Crit Care Med; 1998 Aug; 26(8):1433-6. PubMed ID: 9710105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine--bolus or infusion prophylaxis for stress ulcer.
    Morris DL; Markham SJ; Beechey A; Hicks F; Summers K; Lewis P; Stannard V; Hutchinson A; Byrne AJ
    Crit Care Med; 1988 Mar; 16(3):229-32. PubMed ID: 3277779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonia and stress ulceration in severely injured patients. A prospective evaluation of the effects of stress ulcer prophylaxis.
    Fabian TC; Boucher BA; Croce MA; Kuhl DA; Janning SW; Coffey BC; Kudsk KA
    Arch Surg; 1993 Feb; 128(2):185-91; discussion 191-2. PubMed ID: 8431119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine and gastrointestinal bleeding in intensive care. Should prophylaxis against stress ulcer be abondoned for patients in intensive care.
    Preiser JC
    BMJ; 2001 Apr; 322(7292):995. PubMed ID: 11339222
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal therapy for stress gastritis.
    Maier RV; Mitchell D; Gentilello L
    Ann Surg; 1994 Sep; 220(3):353-60; discussion 360-3. PubMed ID: 8092901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two intravenous ranitidine regimens in a homogeneous population of intensive care unit patients.
    Geus WP; Vinks AA; Smith SJ; Westra P; Lamers CB
    Aliment Pharmacol Ther; 1993 Aug; 7(4):451-7. PubMed ID: 8218759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
    Cook D; Heyland D; Griffith L; Cook R; Marshall J; Pagliarello J
    Crit Care Med; 1999 Dec; 27(12):2812-7. PubMed ID: 10628631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ranitidine in a homogeneous population of intensive care unit patients during intermittent and continuous administration.
    Geus WP; Vinks AA; Lamers CB
    Scand J Gastroenterol Suppl; 1992; 194():55-8. PubMed ID: 1298048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
    Kiilerich S; Rannem T; Elsborg L
    Digestion; 1995; 56(1):25-30. PubMed ID: 7895928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.